CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection

Project: Other project

StatusFinished
Effective start/end date12/5/135/23/15

Funding

  • DUKE UNIVERSITY: $10,219.00